黑料网

ISSN: 2161-1165

Epidemiology: 黑料网
黑料网

Our Group organises 3000+ Global Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ 黑料网 Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

黑料网 Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
Citations : 3849

Indexed In
  • Index Copernicus
  • Google Scholar
  • Sherpa Romeo
  • Genamics JournalSeek
  • SafetyLit
  • Access to Global Online Research in Agriculture (AGORA)
  • Centre for Agriculture and Biosciences International (CABI)
  • RefSeek
  • Hamdard University
  • EBSCO A-Z
  • OCLC- WorldCat
  • CABI full text
  • Cab direct
  • Publons
  • Geneva Foundation for Medical Education and Research
  • Euro Pub
  • ICMJE
Share This Page
 

Dr. Massoud Toussi

Dr. Massoud Toussi

Editor-in-Chief
Dr. Massoud Toussi
Head of Epidemiology and Drug Safety
France
Tel:33 (6) 86 61 75 06

Biography

Massoud Toussi is Pharmacoepidemiology and drug safety lead for North Europe and Africa in IMS Health. He brings his knowledge and experience in medical, methodological and operational aspects of clinical and epidemiological research to guarantee the quality of interventional, observational and database studies. Massoud is medical doctor (M.D) with a Master of science MSc in medical informatics and health technology as well as a Doctor of Philosophy (PhD) in medical data analysis. He also holds a master of business administration (MBA) . He is a frequent lecturer in different professional conferences and is an active member of the International Society of Pharmacoepidemiology (ISPE), European Network of centers of Pharmacoepidemiology and Pharmacovigilance (ENCePP) and European Public Health Association (EUPHA). His domains of interest are pharmacoepidemiology, drug safety and the measurement of benefit-risk balance of drugs and health technologies. He has experience in most therapeutic domains with special interest in diabetes and psychiatry.

Research Interest

International Conferences 2024-25
 
Meet Inspiring Speakers and Experts at our 3000+ Global

Conferences by Country

Medical & Clinical Conferences

Conferences By Subject

Top